Profile
| Metric | Value |
|---|---|
| Full Name | GeneDx Holdings Corp. |
| Ticker | NASDAQ: WGS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | genedx.com |
| Employees | 1,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $84.47 | |
| Price, 1D Change | -1.03% | |
| $2B | ||
| - | ||
| 1,400.83 | ||
| 1.63 | ||
| $305M | ||
| Revenue, 1Y Change | +50.79% | |
| -$1.94 | ||
| EPS, 1Y Change | +73.11% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:33 | |
| Next Split | N/A | N/A |
| Last Ticker Change | SMFR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.94 | ||
| EPS Estimate | $1.39 | |
| EPS Est. Change | +171.27% | |
| $305.45M | ||
| Revenue Estimate | $426.92M | |
| Revenue Est. Change | +39.77% | |
| Current Price | $84.47 | |
| Price Target | - | $170.00 |
| Price Tgt. Change | - | +101.25% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.50 | -$7.23 | -31.45% | |
| -$0.35 | -$1.94 | -455.54% | |
| $1.39 | N/A | +171.27% | |
| $0.63 | N/A | +132.30% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $202.57M | $202.57M | 0.00% | |
| $290.82M | $305.45M | +5.03% | |
| $426.92M | N/A | +39.77% | |
| $541.99M | N/A | +77.44% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $84.47 | |
| $109.87 | ||
| SMA 200 vs Price | +30.07% | |
| $131.40 | ||
| SMA 50 vs Price | +55.56% | |
| 1.63 | ||
| $7.82 | ||
| 25.46 | ||
| 76.59% | ||
| 95.84% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $305.45M | ||
| -$1.94 | ||
| $194.40M | ||
| 63.64% | ||
| -$23.21M | ||
| -7.60% | ||
| -$52.29M | ||
| -17.12% | ||
| -$1.26M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.48 | ||
| 3.61 | ||
| 3.42 | ||
| - | ||
| 8 | ||
| 3.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 1,400.83 | ||
| 6.07 | ||
| 8.35 | ||
| 68.76 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $245.25M | ||
| $141.19M | ||
| $464.70M | ||
| $197.97M | ||
| $219.46M | ||
| $54.82M | ||
| $117.38M | ||
| $4.55M | ||
| $7.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $328.66M | ||
| $217.61M | ||
| $111.05M | ||
| $168.48M | ||
| $21.95M | ||
| $0.00 | ||
| -$343.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$28.50M | ||
| -$30.13M | ||
| $44.16M | ||
| $5.49M | ||
| -$33.99M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Wells Fargo | → | |
| BTIG | → | |
| Wells Fargo | → | |
| Guggenheim | → | |
| Canaccord Genuity | → | |
| BTIG | → | |
| BTIG | → | |
| Canaccord Genuity | ||
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with WGS
FAQ
What is the ticker symbol for GeneDx Holdings Corp.?
The ticker symbol for GeneDx Holdings Corp. is NASDAQ:WGS
Does GeneDx Holdings Corp. pay dividends?
No, GeneDx Holdings Corp. does not pay dividends
What sector is GeneDx Holdings Corp. in?
GeneDx Holdings Corp. is in the Healthcare sector
What industry is GeneDx Holdings Corp. in?
GeneDx Holdings Corp. is in the Diagnostics & Research industry
What country is GeneDx Holdings Corp. based in?
GeneDx Holdings Corp. is headquartered in United States
When did GeneDx Holdings Corp. go public?
GeneDx Holdings Corp. initial public offering (IPO) was on November 4, 2020
Is GeneDx Holdings Corp. in the S&P 500?
No, GeneDx Holdings Corp. is not included in the S&P 500 index
Is GeneDx Holdings Corp. in the NASDAQ 100?
No, GeneDx Holdings Corp. is not included in the NASDAQ 100 index
Is GeneDx Holdings Corp. in the Dow Jones?
No, GeneDx Holdings Corp. is not included in the Dow Jones index
When was GeneDx Holdings Corp. last earnings report?
GeneDx Holdings Corp.'s most recent earnings report was on October 28, 2025
When does GeneDx Holdings Corp. report earnings?
The next expected earnings date for GeneDx Holdings Corp. is February 23, 2026
Data Sources & References
- WGS Official Website www.genedx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1818331/000181833125000130/0001818331-25-000130-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1818331/000181833125000021/0001818331-25-000021-index.htm
- WGS Profile on Yahoo Finance finance.yahoo.com/quote/WGS
- WGS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wgs